2002
DOI: 10.1093/humrep/17.7.1762
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-guided embryo transfer improves pregnancy rates and increases the frequency of easy transfers

Abstract: BACKGROUND: Recent reports have suggested that ultrasound (US) guidance during embryo transfer might improve pregnancy rates. METHODS: A prospective randomized (computer-generated random table) trial was performed to compare embryo transfer under abdominal US guidance (n ⍧ 255 women) with clinical touch embryo transfer (n ⍧ 260). RESULTS: The clinical pregnancy rate was 26.3% (67/255) in the US-guided transfer group compared with 18.1% (47/260) in the clinical touch transfer group (P < 0.05). The implantation … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
75
0
1

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 118 publications
(80 citation statements)
references
References 26 publications
1
75
0
1
Order By: Relevance
“…Our IVF protocol has been described previously [11][12][13]. Briefly, it consists of down-regulation with gonadotrophinreleasing hormone analogue, triptorelin acetate (Decapeptyl, Ipsen Farma, Madrid, Spain) on a long protocol; ovarian stimulation with recombinant FSH (Gonal F, Merck Serono, Madrid, Spain) and highly purified urinary menopausal gonadotropins (Menopur, Ferring, Madrid Spain) or recombinant LH (Luveris, Merck Serono), follicular growth being monitored by measuring plasma estradiol levels and vaginal ultrasound; and triggering of ovulation with 250 μg r-hCG (Ovitrelle, Merck Serono) when at least 3 follicles >18.5 mm are observed.…”
Section: Methodsmentioning
confidence: 99%
“…Our IVF protocol has been described previously [11][12][13]. Briefly, it consists of down-regulation with gonadotrophinreleasing hormone analogue, triptorelin acetate (Decapeptyl, Ipsen Farma, Madrid, Spain) on a long protocol; ovarian stimulation with recombinant FSH (Gonal F, Merck Serono, Madrid, Spain) and highly purified urinary menopausal gonadotropins (Menopur, Ferring, Madrid Spain) or recombinant LH (Luveris, Merck Serono), follicular growth being monitored by measuring plasma estradiol levels and vaginal ultrasound; and triggering of ovulation with 250 μg r-hCG (Ovitrelle, Merck Serono) when at least 3 follicles >18.5 mm are observed.…”
Section: Methodsmentioning
confidence: 99%
“…The embryo transfer can be performed in three ways: (1) blind (clinical touch); (2) based on information on the length of the uterus (obtained by previous ultrasonographic measurement or mock transfer); (3) guided by abdominal ultrasonography. It is advantageous to place the embryos into the uterus in as atraumatic a manner as possible [1][2][3]. Uterine contractions [4,5], presence of blood on the catheter [6,7], bacterial contamination of the catheter [8], difficulty of transfer [9], and the type of catheter [10][11][12][13], all influence the success rate of the IVF/ICSI treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, ultrasound-guided embryo transfer has been reported to improve the clinical pregnancy rate after IVF. For example, the clinical pregnancy rate among those undergoing embryo transfer with ultrasound guidance has been reported in the range of 38.4-50%, considerably higher than the 25.4-33.7%, reported for those embryo transfer was not assisted by ultrasound (4)(5)(6)(7)(8). Conversely, one study did not show any statistical difference in the pregnancy rate between the ultrasound-guided group (26.0%) and the nonultrasound-guided group (22.5%) (9).…”
Section: Introductionmentioning
confidence: 90%